Reason for request

First listing

Summary of opinion.

Favourable opinion for reimbursement in the symptomatic treatment of mild to moderate pain and/or fever.

 


Clinical Benefit

Substantial

The Committee issues a favourable opinion for inclusion in both the list of covered drugs for outpatients and the list of covered drugs for inpatients approved for use in the indication and at the MA dosages.


Clinical Added Value

no clinical added value

These medicinal products are a range supplement that do not provide any clinical added value (CAV V) compared to the forms already listed.


Contact Us

Évaluation des médicaments